United Lithium Encounters 3.33% Lithium Oxide In Sampling At Bergby
United Lithium (CSE: ULTH) this morning released the first results from its sampling program at its Bergby Lithium Project in Sweden. Exploration was focused west of the previously drilled region on the property, where the company conducted sampling on several boulders. Sampling results released this morning include samples returning 3.01% lithium oxide, as well as […]
Workhorse Group Sees CFO, COO Depart Company
Workhorse Group (NASDAQ: WKHS) this morning issued a serious of announcements related to executive leadership changes at the company. Buried within the body of the release, is the news that two of the firms top executives have seemingly decided to leave the company at the same time for undisclosed reasons. Chief among the departures is […]
New Found Gold Releases Further Assays At Golden Joint Zone
New Found Gold (TSXV: NFG) this morning reported further drill results from its ongoing exploration program at its Queensway property. The latest results come from the Golden Joint zone, which lays between the Lotto and Keats zones on the property. Results released this morning consist of assays from eight drill holes. Highlights from the results […]
Qyou Media Lifts Q1 2022 Revenue Guidance By 51%
Business appears to be absolutely booming for Qyou Media (TSXV: QYOU). The youth-oriented media firm this morning revised its previously issued revenue guidance, with guidance improving by an impressive 51.6% for its first quarter 2022 financial results. Previously pegged at between $3.1 million and $3.8 million, the company this morning dramatically improved its revenue guidance […]
Did Robinhood’s President Trade AMC And GME On Material Non-Public Information?
Earlier today, the documents of a class action lawsuit against Robinhood Markets (NASDAQ: HOOD) were forced into the limelight. One Twitter user, @unusual_whales, made public certain aspects of the document that don’t particularly cast the company in a positive light – leading to the equity selling off 3.49% by the end of the trading session. […]
Jerome Powell Finally Concedes Inflation is Rampant, Sen. Warren Calls Him a ‘Dangerous Man’ to Lead the Fed
Major US stocks and indices were sent sharply plummeting on Tuesday, as markets began to price in a stagflation recipe of upcoming interest rate hikes, surging inflation, and reduced economic output. The S&P 500 sank more than 2% while the Nasdaq Composite was down nearly 3% at the time of writing, marking the wort day […]
BMO Lowers Take-Two Interactive’s Price Target By $75 Following Continuous Delays
Last week Take-Two Interactive (NASDAQ: TTWO) announced that they reiterated their 2022 guidance and outlook. They additionally noted that their highly anticipated expanded and enhanced versions of Grand Theft Auto V and Grand Theft Auto Online for PlayStation 5 and Xbox Series X|S, which was originally planned for a November 11th, 2021 release, is being delayed […]
European Gas Prices Soar to Historical High as Energy Crisis Worsens
Another day, another record-high for energy markets… As Europe and the UK continue to sleepwalk into an energy crisis that is spreading across the globe, natural gas prices across the continent soared to yet a new record-high on Tuesday, as October futures on the Dutch TTF exchange skyrocketed by 12% to $29.19 per million Btu— […]
Mashinsky: The Last Time You’re Going To Get Bitcoin At These Prices – The Daily Dive
We welcome to the Daily Dive for the first time Alex Mashinsky, the founder and CEO of Celsius Network. He joins us to talk about the company’s framework and rapid growth, his thoughts on bitcoin, the biggest risks he sees in the crypto market, and the regulations around the space. Celsius addresses the financial needs […]
Canaccord Slashes Antibe Therapeutics Price Target A Month After Drug Trial Paused
On August 3, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study of otenaproxesul because it breached the threshold for the number of patients exhibiting liver transaminase elevations. Two analysts lowered their price target on the stock thereafter. Antibe Therapeutics currently has 6 analysts covering the stock with a weighted 12-month price […]